AU Patent

AU2012275036A1 — Bazedoxifene acetate formulations and manufacturing process thereof

Assigned to Wyeth LLC · Expires 2013-01-24 · 13y expired

What this patent protects

The present invention is directed to formulations of bazedoxifene acetate that have reduced polymorph conversion, compositions containing the same, preparations thereof, and uses thereof.

USPTO Abstract

The present invention is directed to formulations of bazedoxifene acetate that have reduced polymorph conversion, compositions containing the same, preparations thereof, and uses thereof.

Drugs covered by this patent

Patent Metadata

Patent number
AU2012275036A1
Jurisdiction
AU
Classification
—
Expires
2013-01-24
Drug substance claim
No
Drug product claim
No
Assignee
Wyeth LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.